John Wiley & Sons, Inc. (NYSE:WLYB – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $39.20, but opened at $36.05. John Wiley & Sons shares last traded at $36.01, with a volume of 883 shares trading hands.
John Wiley & Sons Stock Performance
The firm has a market capitalization of $2.04 billion, a PE ratio of -12.94 and a beta of 0.77. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.54 and a quick ratio of 0.50. The firm has a fifty day moving average price of $36.10 and a 200 day moving average price of $33.40.
John Wiley & Sons (NYSE:WLYB – Get Free Report) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.59 earnings per share for the quarter. The firm had revenue of $460.71 million for the quarter. John Wiley & Sons had a positive return on equity of 18.83% and a negative net margin of 8.14%.
John Wiley & Sons Announces Dividend
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. Morgan Stanley increased its position in John Wiley & Sons by 14,570,300.0% in the 4th quarter. Morgan Stanley now owns 145,704 shares of the company’s stock worth $5,755,000 after purchasing an additional 145,703 shares during the last quarter. Royal Bank of Canada acquired a new position in John Wiley & Sons in the 3rd quarter worth about $1,679,000. Dimensional Fund Advisors LP acquired a new position in John Wiley & Sons in the 3rd quarter worth about $856,000. Neuberger Berman Group LLC acquired a new position in John Wiley & Sons in the 3rd quarter worth about $384,000. Finally, UBS Group AG acquired a new position in John Wiley & Sons in the 3rd quarter worth about $355,000. 0.49% of the stock is owned by institutional investors and hedge funds.
About John Wiley & Sons
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
Featured Stories
- Five stocks we like better than John Wiley & Sons
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Comprehensive Analysis of PayPal Stock
- 3 Stocks to Consider Buying in October
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- When to Sell a Stock for Profit or Loss
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.